Rotarix® vaccine replaces RotaTeq® vaccine from 1 July 2017
Following a recent Commonwealth government tendering process, Rotarix® vaccine is to replace RotaTeq® vaccine from 1 July 2017 across Australia.
The oral rotavirus vaccine Rotarix®, is a 2-dose schedule at 2 months (from 6 weeks) and 4 months of age. This means the oral rotavirus vaccine will no longer be required at the 6 month old schedule point.
Rotarix® age restrictions apply. The 1st dose must be administered prior to 15 weeks of age and the 2nd dose prior to 25 weeks of age.
Reduce stock of RotaTeq® vaccine in preparation for switching to Rotarix® vaccine. When ordering rotavirus vaccine, Rotarix® vaccine will be delivered later in June. It is a 2 dose course so less stock is needed.
Read the ATAGI Clinical advice for information (and a document) on how to use rotavirus vaccines during the brand switch period - see Table 1 of the document.
Be familiar with potential scenarios and responses during RotaTeq® to Rotarix® switch period - see Table 2 in the document.
Read the evidence for vaccine effectiveness and safety of mixed or reduced dose schedules.